ArticleJournal of neuroinflammation2016

New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.

T Sehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.